Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429284 · ClinicalTrials.gov registry record
U.S. CTEPH Registry
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 754
- Enrollment target
NCT02429284: Completed study, sponsored by University of California, San Diego.
NCT02429284 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 754 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02429284 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 754 participants
- Enrollment target
Study Summary
The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension. The mission of the Registry will be to promote a greater understanding of the prevalence, pathophysiology, evaluation, and treatment of patients with CTEPH through shared information, education, and collaborative investigation among pulmonary hypertension (PH) centers of excellence throughout the U.S.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2015-04 |
| Est. Completion | 2019-11 |
What the finished NCT02429284 record still lists
NCT02429284 is an observational study that tracks outcomes without assigning an intervention. The registered 754 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02429284 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02429284 about?
NCT02429284 is a clinical study titled "U.S. CTEPH Registry". The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension. The mission of the Registry will be to promote a gr...
What is the current status of trial NCT02429284?
This trial is currently completed. The enrollment target is 754 participants. The study started on 2015-04. Estimated completion is 2019-11.
Who is sponsoring clinical trial NCT02429284?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia